SVNT Share Price

Open 26.00 Change Price %
High 26.25 1 Day 0.75 2.94
Low 25.00 1 Week 2.25 9.38
Close 26.25 1 Month 2.20 9.15
Volume 69791 1 Year 26.19 43650.00
52 Week High 26.25
52 Week Low 14.75
SVNT Important Levels
Resistance 2 27.41
Resistance 1 26.93
Pivot 25.83
Support 1 25.57
Support 2 25.09
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.67 0.17%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OPXAW 0.01 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Savient Pharmaceuticals Inc (NASDAQ: SVNT)

SVNT Technical Analysis 5
As on 2nd Dec 2016 SVNT Share Price closed @ 26.25 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 7.28 & Strong Buy for SHORT-TERM with Stoploss of 22.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
SVNT Target for December
1st Target up-side 24.95
2nd Target up-side 25.37
3rd Target up-side 25.79
1st Target down-side 23.77
2nd Target down-side 23.35
3rd Target down-side 22.93
Savient Pharmaceuticals Inc ( NASDAQ USA Symbol : SVNT )
Sector : Consumer Durables Specialty Chemicals And Other Stocks in Same Sector
SVNT
26.25 0.75 (2.94 %)
LT : Strong Buy
ST : Strong Buy
SVNT Other Details
Segment EQ
Market Capital 108615704.00
Sector Consumer Durables Specialty Chemicals
Industry
Offical website
SVNT Address
SVNT
N/A
Interactive Technical Analysis Chart Savient Pharmaceuticals Inc ( SVNT NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Savient Pharmaceuticals Inc
SVNT Business Profile
Savient Pharmaceuticals, Inc. (Savient), incorporated in 1980, is a specialty biopharmaceutical company focused on commercializing KRYSTEXXA (pegloticase) in the United States and completing the development and seeking regulatory approval outside of the United States for KRYSTEXXA, particularly in the European Union. The Company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. In October 2013, the Company announced that it has elected to file voluntary petitions under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the Court). Effective January 10, 2014, Crealta Pharmaceuticals LLC, a majority owned unit of GTCR LLC acquired Savient Pharmaceuticals Inc.